(19)
(11) EP 4 329 827 A1

(12)

(43) Date of publication:
06.03.2024 Bulletin 2024/10

(21) Application number: 22720521.8

(22) Date of filing: 26.04.2022
(51) International Patent Classification (IPC): 
A61K 51/08(2006.01)
A61P 35/00(2006.01)
A61K 51/10(2006.01)
A61K 103/00(2006.01)
(52) Cooperative Patent Classification (CPC):
A61K 51/088; A61K 51/10; A61P 35/00
(86) International application number:
PCT/NL2022/050224
(87) International publication number:
WO 2022/231424 (03.11.2022 Gazette 2022/44)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
KH MA MD TN

(30) Priority: 26.04.2021 NL 2028075

(71) Applicant: Alphathera AG
4052 Bazel (CH)

(72) Inventors:
  • MARING, Markwin Hendrik
    3047AC Rotterdam (NL)
  • MONSTER, Elmer
    4123 Allschwil (CH)
  • VAN BODEGOM, Jan
    3047 AC Rotterdam (CH)

(74) Representative: Patent Business B.V. 
Lange Amerikaweg 81
7332 BP Apeldoorn
7332 BP Apeldoorn (NL)

   


(54) TARGETING SYSTEM FOR CANCER COMPRISING A RADIOISOTOPE